Bio-Thera Solutions, Ltd. (SHA:688177)
26.32
+0.02 (0.08%)
At close: May 30, 2025, 2:57 PM CST
Bio-Thera Solutions Revenue
Bio-Thera Solutions had revenue of 206.56M CNY in the quarter ending March 31, 2025, with 27.83% growth. This brings the company's revenue in the last twelve months to 788.13M, up 10.78% year-over-year. In the year 2024, Bio-Thera Solutions had annual revenue of 743.17M with 5.44% growth.
Revenue (ttm)
788.13M
Revenue Growth
+10.78%
P/S Ratio
13.72
Revenue / Employee
630.00K
Employees
1,251
Market Cap
10.82B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 743.17M | 38.37M | 5.44% |
Dec 31, 2023 | 704.79M | 249.66M | 54.86% |
Dec 31, 2022 | 455.13M | -381.45M | -45.60% |
Dec 31, 2021 | 836.58M | 653.72M | 357.49% |
Dec 31, 2020 | 182.86M | 182.16M | 26,023.37% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Sichuan Biokin Pharmaceutical | 5.82B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |